Amy Franke
Direttore Tecnico/Scientifico/R&S presso SHATTUCK LABS, INC.
Profilo
Amy Franke is currently the Vice President-Clinical Operations at Shattuck Labs, Inc. She previously worked as the Senior Director-Strategy & Planning at Labcorp Drug Development, Inc., Vice President-Clinical Operations at NervGen Pharma Corp., and Vice President-Clinical Operations at Aravive, Inc. Ms. Franke completed her undergraduate degree at the University of Michigan and her graduate degree at the University of Pennsylvania Medical Center.
Posizioni attive di Amy Franke
| Società | Posizione | Inizio |
|---|---|---|
| SHATTUCK LABS, INC. | Direttore Tecnico/Scientifico/R&S | 01/10/2022 |
Precedenti posizioni note di Amy Franke
| Società | Posizione | Fine |
|---|---|---|
| ARAVIVE, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2022 |
| COVANCE INC. | Corporate Officer/Principal | - |
| NERVGEN PHARMA CORP. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Amy Franke
| University of Pennsylvania Medical Center | Graduate Degree |
| University of Michigan | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| NERVGEN PHARMA CORP. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| SHATTUCK LABS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Pharmaceuticals: MajorHealth Technology Covance, Inc. operates as a contract research organization and drug development company. Its services include research, lead optimization, analysis services, safety assessment and drug safety testing, consulting and partnering, clinical development, informatics, clinical testing, commercialization, and manufacturing support. The company was founded on November 12, 1996 and is headquartered in Princeton, NJ. | Health Technology |
- Borsa valori
- Insiders
- Amy Franke